Exosomes in Cancer: Diagnostic and Therapeutic Applications
Overview
Affiliations
Small extracellular vesicles called exosomes are produced by cells and contain a range of biomolecules, including proteins, lipids, and nucleic acids. Exosomes have been implicated in the development and spread of cancer, and recent studies have shown that their contents may be exploited as biomarkers for early detection and ongoing surveillance of the disease. In this review article, we summarize the current knowledge on exosomes as biomarkers of cancer. We discuss the various methods used for exosome isolation and characterization, as well as the different types of biomolecules found within exosomes that are relevant for cancer diagnosis and prognosis. We also highlight recent studies that have demonstrated the utility of exosomal biomarkers in different types of cancer, such as lung cancer, breast cancer, and pancreatic cancer. Overall, exosomes show great promise as noninvasive biomarkers for cancer detection and monitoring. Exosomes have the ability to transform cancer diagnostic and therapeutic paradigms, providing promise for more efficient and individualized. This review seeks to serve as an inspiration for new ideas and research in the never-ending fight against cancer. Moreover, further studies are needed to validate their clinical utility and establish standardized protocols for their isolation and analysis. With continued research and development, exosomal biomarkers have the potential to revolutionize cancer diagnosis and treatment.
Asaturova A, Zaretsky A, Rogozhina A, Tregubova A, Badlaeva A J Clin Med. 2025; 13(24.
PMID: 39768459 PMC: 11728107. DOI: 10.3390/jcm13247538.
Clinical applications of circulating biomarkers in non-small cell lung cancer.
Oh H, Imam-Aliagan A, Kim Y, Kim H, Izaguirre I, Sung C Front Cell Dev Biol. 2024; 12:1449232.
PMID: 39239557 PMC: 11375801. DOI: 10.3389/fcell.2024.1449232.
The role of ncRNAs and exosomes in the development and progression of endometrial cancer.
Niebora J, Wozniak S, Domagala D, Data K, Farzaneh M, Zehtabi M Front Oncol. 2024; 14:1418005.
PMID: 39188680 PMC: 11345653. DOI: 10.3389/fonc.2024.1418005.
Wang Y, Ma H, Zhang X, Xiao X, Yang Z J Inflamm Res. 2024; 17:5005-5024.
PMID: 39081872 PMC: 11287202. DOI: 10.2147/JIR.S475102.